L+G-L+G PHARMA BREAKTHR.
L+G-L+G PHARMA BREAKTHR.
ETF · IE00BF0H7608 · A2H9XR (XLON)
Overview
No Price
Closing Price XLON 03.11.2025: 13,06 USD
03.11.2025 15:59
Current Prices from L+G-L+G PHARMA BREAKTHR.
ExchangeTickerCurrencyLast TradePriceDaily Change
XLON: London
London
BIOT.L
USD
03.11.2025 15:59
13,06 USD
-0,21 USD
-1,55 %
XETR: XETRA
XETRA
ETLI.DE
EUR
03.11.2025 15:53
11,33 EUR
-0,15 EUR
-1,34 %
XLON: London
London
BIGT.L
GBX
03.11.2025 15:49
993,50 GBX
-14,38 GBX
-1,43 %
Company Profile for L+G-L+G PHARMA BREAKTHR. ETF
The L&G Pharma Breakthrough UCITS ETF (the Fund) is an exchange traded fund (ETF) that aims to track the performance of the Solactive Pharma Breakthrough Value Index Net Total Return (the Index) subject to the deduction of the ongoing charges and other costs associated with operating the Fund.
Get up to date insights from finAgent about L+G-L+G PHARMA BREAKTHR.

Company Data

Name L+G-L+G PHARMA BREAKTHR.
Company L&G Pharma Breakthrough UCITS ETF
Primary Exchange XLON London
WKN A2H9XR
ISIN IE00BF0H7608
Asset Class ETF
Sector Financial Services
Industry Asset Management
Market Capitalization 14 Mio
Country Ireland
Currency EUR
Employees -
IPO Date 2018-01-18

Ticker Symbols

Name Symbol
Frankfurt ETLI.F
London BIGT.L
London BIOT.L
XETRA ETLI.DE
More Shares
Investors who hold L+G-L+G PHARMA BREAKTHR. also have the following shares in their portfolio:
GS F.C.INTL 24/26 MTN
GS F.C.INTL 24/26 MTN Bond
sinops Inc.
sinops Inc. Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025